Division of Nutritional Sciences, Cornell University, Ithaca, NY, USA.
Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
Adv Nutr. 2021 Oct 1;12(5):1838-1853. doi: 10.1093/advances/nmab035.
Iron is unique among all minerals in that humans have no regulatable excretory pathway to eliminate excess iron after it is absorbed. Iron deficiency anemia occurs when absorbed iron is not sufficient to meet body iron demands, whereas iron overload and subsequent deposition of iron in key organs occur when absorbed iron exceeds body iron demands. Over time, iron accumulation in the body can increase risk of chronic diseases, including cirrhosis, diabetes, and heart failure. To date, only ∼30% of the interindividual variability in iron absorption can be captured by iron status biomarkers or iron regulatory hormones. Much of the regulation of iron absorption may be under genetic control, but these pathways have yet to be fully elucidated. Genome-wide and candidate gene association studies have identified several genetic variants that are associated with variations in iron status, but the majority of these data were generated in European populations. The purpose of this review is to summarize genetic variants that have been associated with alterations in iron status and to highlight the influence of ethnicity on the risk of iron deficiency or overload. Using extant data in the literature, linear mixed-effects models were constructed to explore ethnic differences in iron status biomarkers. This approach found that East Asians had significantly higher concentrations of iron status indicators (serum ferritin, transferrin saturation, and hemoglobin) than Europeans, African Americans, or South Asians. African Americans exhibited significantly lower hemoglobin concentrations compared with other ethnic groups. Further studies of the genetic basis for ethnic differences in iron metabolism and on how it affects disease susceptibility among different ethnic groups are needed to inform population-specific recommendations and personalized nutrition interventions for iron-related disorders.
铁是所有矿物质中独一无二的,因为人类没有可调节的排泄途径来消除吸收后多余的铁。当吸收的铁不足以满足身体对铁的需求时,就会发生缺铁性贫血;而当吸收的铁超过身体对铁的需求时,就会发生铁过载和随后铁在关键器官中的沉积。随着时间的推移,体内铁的积累会增加患慢性疾病的风险,包括肝硬化、糖尿病和心力衰竭。迄今为止,只有约 30%的个体间铁吸收的差异可以通过铁状态标志物或铁调节激素来捕捉。铁吸收的很大一部分可能受到遗传控制,但这些途径尚未完全阐明。全基因组和候选基因关联研究已经确定了几个与铁状态变化相关的遗传变异,但这些数据大多是在欧洲人群中产生的。本综述的目的是总结与铁状态变化相关的遗传变异,并强调种族对缺铁或铁过载风险的影响。利用文献中的现有数据,构建了线性混合效应模型来探索铁状态生物标志物的种族差异。这种方法发现,东亚人的铁状态指标(血清铁蛋白、转铁蛋白饱和度和血红蛋白)浓度明显高于欧洲人、非裔美国人或南亚人。与其他种族群体相比,非裔美国人的血红蛋白浓度明显较低。需要进一步研究铁代谢的遗传基础,以及它如何影响不同种族群体的疾病易感性,以便为与铁相关的疾病提供特定人群的建议和个性化营养干预。